(CL) Colgate-Palmolive - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1941621039

CL: Toothpaste, Soap, Shampoo, Detergent, Cleaners, Petfood

Colgate-Palmolive Company (NYSE:CL) is a storied consumer goods giant with a footprint that spans over two centuries. Founded in 1806 and headquartered in New York, the company operates in two primary segments: Oral, Personal, and Home Care, and Pet Nutrition. The first segment is a powerhouse, offering a wide array of everyday essentials like toothpaste, toothbrushes, mouthwash, and hand soaps under iconic brands such as Colgate, Palmolive, and Irish Spring. It also extends into premium skincare with brands like Filorga and PCA SKIN, catering to evolving consumer demands for higher-end personal care products. This segments reach is extensive, with distribution across traditional retail, wholesale, and a growing presence in eCommerce.

The Pet Nutrition segment is another critical pillar, dominated by the Hills Science Diet and Hills Prescription Diet brands. These products are tailored to meet the nutritional needs of pets, ranging from everyday nutrition to specialized, veterinarian-recommended diets. The segments distribution channels include pet supply retailers, veterinarians, and online platforms, ensuring accessibility for pet owners globally. This vertical has significant growth potential, given the rising trend of pet humanization and increased spending on pet health.

From a financial perspective, Colgate-Palmolives market cap stands at approximately $70 billion, reflecting its scale and stability. The companys P/E ratio of 24.70 indicates a premium valuation, likely due to its consistent cash flows and market leadership. The forward P/E of 22.94 suggests expectations of continued earnings growth. While the P/B ratio of 334.36 appears high, it underscores the markets confidence in the companys intangible assets, particularly its strong brand portfolio. The P/S ratio of 3.49 highlights reasonable revenue multiples for a consumer staples giant with a proven track record.

For investors and fund managers, Colgate-Palmolive represents a classic defensive play in the consumer staples sector. Its diversified portfolio of brands, steady cash flows, and global distribution network provide resilience against economic downturns. Additionally, the companys commitment to innovation and sustainability initiatives aligns with evolving consumer preferences, positioning it well for long-term growth. The stocks stability and dividend history make it a favored choice for income-seeking investors looking to balance their portfolios.

Additional Sources for CL Stock

CL Stock Overview

Market Cap in USD 72,608m
Sector Consumer Defensive
Industry Household & Personal Products
GiC Sub-Industry Household Products
IPO / Inception 1977-01-03

CL Stock Ratings

Growth 5y 39.8%
Fundamental 66.6%
Dividend 58.6%
Rel. Strength Industry -5.74
Analysts 3.74/5
Fair Price Momentum 83.82 USD
Fair Price DCF 100.97 USD

CL Dividends

Dividend Yield 12m 2.19%
Yield on Cost 5y 3.02%
Annual Growth 5y 2.50%
Payout Consistency 99.6%

CL Growth Ratios

Growth Correlation 3m -85.9%
Growth Correlation 12m 20%
Growth Correlation 5y 67.5%
CAGR 5y 6.20%
CAGR/Max DD 5y 0.30
Sharpe Ratio 12m 0.19
Alpha 0.64
Beta 0.09
Volatility 20.00%
Current Volume 4747.3k
Average Volume 20d 4690.5k
What is the price of CL stocks?
As of February 22, 2025, the stock is trading at USD 89.47 with a total of 4,747,346 shares traded.
Over the past week, the price has changed by +3.99%, over one month by +1.41%, over three months by -4.53% and over the past year by +7.16%.
Is Colgate-Palmolive a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Colgate-Palmolive (NYSE:CL) is currently (February 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 66.55 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CL as of February 2025 is 83.82. This means that CL is currently overvalued and has a potential downside of -6.31%.
Is CL a buy, sell or hold?
Colgate-Palmolive has received a consensus analysts rating of 3.74. Therefor, it is recommend to hold CL.
  • Strong Buy: 7
  • Buy: 6
  • Hold: 8
  • Sell: 1
  • Strong Sell: 1
What are the forecast for CL stock price target?
According to ValueRays Forecast Model, CL Colgate-Palmolive will be worth about 90.8 in February 2026. The stock is currently trading at 89.47. This means that the stock has a potential upside of +1.5%.
Issuer Forecast Upside
Wallstreet Target Price 97.3 8.7%
Analysts Target Price 103.1 15.2%
ValueRay Target Price 90.8 1.5%